Clinical trial
Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis
NCT00190268 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00190268 |
|---|---|
| Title | Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis |
| Official title | Multicentric Study, Comparative, Randomized, in Double Knowledge of the Effectiveness (Versus Placebo) of a Salt Of 3,4 - Diaminopyridine in the Treatment of Tiredness During the Multiple Sclerosis |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | 3, 4-diaminopyridine |
| Enrollment | 126 |
| Start date | Feb 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Feb 21, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: